Toxicological Sciences 65, 135-150 (2002)
Copyright © 2002 by the Society of Toxicology
SYSTEMS TOXICOLOGY |
Genomics and Proteomics Analysis of Acetaminophen Toxicity in Mouse Liver
AstraZeneca, Alderley Park, Macclesfield SK10 4TG, Cheshire, United Kingdom
Overdose of acetaminophen (APAP) causes severe centrilobular hepatic necrosis in humans and experimental animals. Here, to explore its mechanism, we administered APAP at subtoxic (150 mg/kg ip) and toxic (500 mg/kg ip) doses to overnight fasted mice. Animals were sacrificed at different time points from 15 min to 4 h postinjection. We assessed liver toxicity by plasma ALT activity and by electron microscopy. Using nylon filter arrays and RTQPCR, we performed genomics analysis in liver. We ran proteomics on liver mitochondrial subfractions using the newly developed quantitative fluorescent 2D-DIGE© method (Amersham Pharmacia Biotech UK Limited). As soon as 15 min postinjection, centrilobular hepatocyte mitochondria were already slightly enlarged and GSH total content dropped by a third at top dose. GM-CSF mRNA, which is a granulocyte specific gene likely coming from resident Kupffer cells, was also induced to its maximum of 3-fold at both doses. Chaperone proteins Hsp10 and Hsp60 were readily decreased by half in mitochondria at both doses, most likely by leaking into cytoplasm. Although APAP is known as an apoptotic trigger, no apoptosis was observed at any time point. Most of the protein changes in mitochondria were present at 15 min postinjection, thus preceding most of the gene regulations. The decrease of ATP synthase subunits and ß-oxidation pathway proteins indicated a loss of energy production. As the morphology of mitochondria was also affected very early at top dose, we concluded that APAP toxicity was a direct action of its known reactive metabolite NAPQI, rather than a consequence of gene regulation. However, the latter will either worsen the toxicity or lead toward cell recovery depending on the cellular damage level.
Key Words: acetaminophen; APAP; genomics; in vivo; Kupffer cells; mitochondria; mouse; oxidative stress; paracetamol; proteomics.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Gao, R. D. Holland, and L.-R. Yu Quantitative proteomics for drug toxicity Brief Funct Genomic Proteomic, April 7, 2009; (2009) elp006v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Kienhuis, M. C. G. van de Poll, H. Wortelboer, M. van Herwijnen, R. Gottschalk, C. H. C. Dejong, A. Boorsma, R. S. Paules, J. C. S. Kleinjans, R. H. Stierum, et al. Parallelogram Approach Using Rat-Human In Vitro and Rat In Vivo Toxicogenomics Predicts Acetaminophen-induced Hepatotoxicity in Humans Toxicol. Sci., February 1, 2009; 107(2): 544 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B van Breemen, H. H. Fong, and N. R Farnsworth Ensuring the safety of botanical dietary supplements Am. J. Clinical Nutrition, February 1, 2008; 87(2): 509S - 513S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Beyer, R. C. Fry, M. R. Lasarev, L. A. McConnachie, L. B. Meira, V. S. Palmer, C. L. Powell, P. K. Ross, T. K. Bammler, B. U. Bradford, et al. Multicenter Study of Acetaminophen Hepatotoxicity Reveals the Importance of Biological Endpoints in Genomic Analyses Toxicol. Sci., September 1, 2007; 99(1): 326 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Heinloth, G. A. Boorman, J. F. Foley, N. D. Flagler, and R. S. Paules Gene Expression Analysis Offers Unique Advantages to Histopathology in Liver Biopsy Evaluations Toxicol Pathol, February 1, 2007; 35(2): 276 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fortuny, M. Kogevinas, M. Garcia-Closas, F. X. Real, A. Tardon, R. Garcia-Closas, C. Serra, A. Carrato, J. Lloreta, N. Rothman, et al. Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1696 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Merrick, M. E. Bruno, J. H. Madenspacher, B. A. Wetmore, J. Foley, R. Pieper, M. Zhao, A. J. Makusky, A. M. McGrath, J. X. Zhou, et al. Alterations in the Rat Serum Proteome during Liver Injury from Acetaminophen Exposure J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 792 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Soga, R. Baran, M. Suematsu, Y. Ueno, S. Ikeda, T. Sakurakawa, Y. Kakazu, T. Ishikawa, M. Robert, T. Nishioka, et al. Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption J. Biol. Chem., June 16, 2006; 281(24): 16768 - 16776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Yohe, K. A. O'Hara, J. A. Hunt, T. J. Kitzmiller, S. G. Wood, J. L. Bement, W. J. Bement, J. G. Szakacs, S. A. Wrighton, J. M. Jacobs, et al. Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1269 - G1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jaeschke and M. L. Bajt Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death Toxicol. Sci., January 1, 2006; 89(1): 31 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Kostrubsky, J. F. Sinclair, S. C. Strom, S. Wood, E. Urda, D. B. Stolz, Y. H. Wen, S. Kulkarni, and A. Mutlib Phenobarbital and Phenytoin Increased Acetaminophen Hepatotoxicity Due to Inhibition of UDP-Glucuronosyltransferases in Cultured Human Hepatocytes Toxicol. Sci., September 1, 2005; 87(1): 146 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Srikanth, A. K. Chakraborti, and A. K. Bachhawat Acetaminophen toxicity and resistance in the yeast Saccharomyces cerevisiae Microbiology, January 1, 2005; 151(1): 99 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Wetmore and B. A. Merrick Invited Review: Toxicoproteomics: Proteomics Applied to Toxicology and Pathology Toxicol Pathol, October 1, 2004; 32(6): 619 - 642. [Abstract] [PDF]
|
|
|
|
|
|
M. L. Bajt, T. R. Knight, J. J. Lemasters, and H. Jaeschke Acetaminophen-Induced Oxidant Stress and Cell Injury in Cultured Mouse Hepatocytes: Protection by N-Acetyl Cysteine Toxicol. Sci., August 1, 2004; 80(2): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Heinloth, R. D. Irwin, G. A. Boorman, P. Nettesheim, R. D. Fannin, S. O. Sieber, M. L. Snell, C. J. Tucker, L. Li, G. S. Travlos, et al. Gene Expression Profiling of Rat Livers Reveals Indicators of Potential Adverse Effects Toxicol. Sci., July 1, 2004; 80(1): 193 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Willett, R. A. Roth, and L. Walker Workshop Overview: Hepatotoxicity Assessment for Botanical Dietary Supplements Toxicol. Sci., May 1, 2004; 79(1): 4 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. JIN, X. O. MAO, B. COTTRELL, B. SCHILLING, L. XIE, R. H. ROW, Y. SUN, A. PEEL, J. CHILDS, G. GENDEH, et al. Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis FASEB J, February 1, 2004; 18(2): 287 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Irwin, G. A. Boorman, M. L. Cunningham, A. N. Heinloth, D. E. Malarkey, and R. S. Paules Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data Toxicol Pathol, January 1, 2004; 32(1_suppl): 72 - 83. [Abstract] [PDF]
|
|
|
|
|
|
N. Guerreiro, F. Staedtler, O. Grenet, J. Kehren, and S.-D. Chibout Toxicogenomics in Drug Development Toxicol Pathol, August 1, 2003; 31(5): 471 - 479. [Abstract] [PDF]
|
|
|
|
|
|
K. Shankar, V. S. Vaidya, U. M. Apte, J. E. Manautou, M. J. J. Ronis, T. J. Bucci, and H. M. Mehendale Type 1 Diabetic Mice Are Protected from Acetaminophen Hepatotoxicity Toxicol. Sci., June 1, 2003; 73(2): 220 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis, April 1, 2003; 24(4): 757 - 770. [Abstract] [Full Text] [PDF]
|
|